Search alternatives:
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
highest increase » highest incidence (Expand Search), slight increase (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search)
small decrease » small increased (Expand Search)
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
highest increase » highest incidence (Expand Search), slight increase (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search)
small decrease » small increased (Expand Search)
-
261
-
262
-
263
-
264
-
265
-
266
-
267
-
268
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
269
-
270
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
271
-
272
-
273
-
274
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
275
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
276
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
277
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
278
-
279
-
280
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: